1992
DOI: 10.1590/s0074-02761992000700049
|View full text |Cite
|
Sign up to set email alerts
|

Successful vaccination against Boophilus microplus and Babesia bovis using recombinat antigens

Abstract: Current methods for the control of the cattle tick Boophilus microplus and the agent of bovine babesiosis, Babesia bovis are unsatisfactory. Effective immunological control of both parasites would have great advantages. However, naturally acquired immunity to the tick is generally unable to prevent serious production losses. A vaccine against the tick, based on a novel form of immunization, is being developed. A protective antigen has been isolated from the tick, characterized and produced as an effective, rec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

1995
1995
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Additionally, vaccines can complement other ixodid control tactics with the aim of mitigating the development of resistance to acaricides [ 250 ] Vaccines can be designed to deploy multiple antigens, enabling protection for a wide range of host species against multiple ixodid species [ 251 ]. As an example of current efforts to develop anti-ixodid vaccines, candidate vaccines are being investigated with the goal of providing prophylactic protection of cattle from R. microplus [ 252 ], while recent efforts using recombinant antitick vaccines afforded nearly 82% efficacy against tick infestation [ 253 ]. Additional vaccine development opportunities exist, with a current focus on improving identification and characterization of ixodid antigens that can then be generated in the laboratory [ 254 ].…”
Section: Vaccinesmentioning
confidence: 99%
“…Additionally, vaccines can complement other ixodid control tactics with the aim of mitigating the development of resistance to acaricides [ 250 ] Vaccines can be designed to deploy multiple antigens, enabling protection for a wide range of host species against multiple ixodid species [ 251 ]. As an example of current efforts to develop anti-ixodid vaccines, candidate vaccines are being investigated with the goal of providing prophylactic protection of cattle from R. microplus [ 252 ], while recent efforts using recombinant antitick vaccines afforded nearly 82% efficacy against tick infestation [ 253 ]. Additional vaccine development opportunities exist, with a current focus on improving identification and characterization of ixodid antigens that can then be generated in the laboratory [ 254 ].…”
Section: Vaccinesmentioning
confidence: 99%
“…Several publications have outlined the stages in the development of Bm86-based vaccines commercialized before (Canales et al 1997;De la Fuente et al 1999;De la Fuente et al 1998;Jittapalapong et al 2006;Rodriguez-Mallon 2016;Willadsen 2008b;Willadsen et al 1992Willadsen et al , 1995. In the case of TickGard®, it took 14 years and testing in thousands of cattle to complete demonstration of feasibility, documentation of efficacy in field trials, completion of product registration, and post-marketing product surveillance to complete the commercialization process (Willadsen 2008b;Willadsen et al 1995).…”
Section: Past Experiences Developing Bm86-based Vaccinesmentioning
confidence: 99%
“…More investment in alternatives for tick control and acaricide resistance management are necessary. Some work has been carried out on biological control, mainly with fungi (Onofre et al 2001), and impressive results can be obtained with tick vaccines (Willadsen et al 1992). The use of resistant hosts has shown to be effective (Frisch, 1999), but more research is needed.…”
Section: A C a R I C I D E R E G I S T R A T I O N U S E M I S-mentioning
confidence: 99%